Invention Grant
- Patent Title: Conjugate comprising P21 protein for the treatment of cancer
- Patent Title (中): 包含用于治疗癌症的P21蛋白的缀合物
-
Application No.: US12608718Application Date: 2009-10-29
-
Publication No.: US09145446B2Publication Date: 2015-09-29
- Inventor: Agamemnon Epenetos , Christina Kousparou
- Applicant: Agamemnon Epenetos , Christina Kousparou
- Applicant Address: GB London
- Assignee: Trojan Technologies, Ltd.
- Current Assignee: Trojan Technologies, Ltd.
- Current Assignee Address: GB London
- Agency: DLA Piper LLP (US)
- Priority: GB0507598.1 20050414
- Main IPC: A61K6/00
- IPC: A61K6/00 ; A61K38/00 ; A61K38/16 ; A61K47/00 ; A61K47/30 ; C07K14/435 ; A61K31/337 ; A61K31/513 ; A61K31/555 ; A61K33/24 ; A61K38/17 ; A61K45/06 ; C07K14/47 ; A61K47/48
Abstract:
The P21 protein is used as a medicament in the treatment of cancer. A conjugate comprises a first region comprising the P21 protein, or a homologue or functional fragment thereof; and a second region comprising a translocation factor.
Public/Granted literature
- US20110021441A1 CONJUGATE COMPRISING P21 PROTEIN FOR THE TREATMENT OF CANCER Public/Granted day:2011-01-27
Information query
